Search
Medtronic's diabetes business, MiniMed, files for IPO to raise up to $100 million
1 week ago /
Read about 0 minute
Author：小编
Recently, MiniMed, a spin-off entity of Medtronic focused on diabetes management devices and technologies, has officially filed documents with the U.S. Securities and Exchange Commission to raise up to $100 million through an IPO. MiniMed plans to list on the Nasdaq under the ticker symbol 'MMED,' with Goldman Sachs and others serving as joint bookrunning managers. Its product range includes insulin pumps, continuous glucose monitors, and more. As of October 2025, it has over 640,000 insulin pump users.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
